U.S. FTC Clears Mars' Acquisition Of Kellanova Without Condition

Mars Inc.'s pending $35.9 billion acquisition of Kellanova (K) for $83.50 per share has received a significant boost as the U.S. Federal Trade Commission completed its antitrust review without imposing any conditions. This clearance marks the 27th of 28 required regulatory approvals, with only the European Commission's review remaining outstanding for the deal, originally announced in August 2024, to finalize.

Analysis

The unconditional clearance by the U.S. Federal Trade Commission for Mars' proposed acquisition of Kellanova (K) represents a critical de-risking milestone for the $35.9 billion transaction. This approval, granted without any required remedies or conditions, successfully navigates a major antitrust hurdle and marks the 27th of 28 necessary regulatory green lights. The deal, priced at $83.50 per share in cash, now hinges solely on the outstanding review by the European Commission. The FTC's decision substantially increases the likelihood of the acquisition closing as planned, shifting the primary focus for shareholders and arbitrage investors to the outcome and timing of the final European regulatory process.

Key Decisions for Investors

• The unconditional FTC approval significantly reduces the deal's risk profile, suggesting investors holding Kellanova (K) for the arbitrage spread should maintain their positions while closely monitoring the European Commission's review.
• Investors should recognize that while the probability of the deal closing has increased, the final European regulatory decision remains a concentrated point of risk that could impact the timeline and final outcome.
• Kellanova's stock price should now trade more tightly to the $83.50 per share cash offer, with the remaining discount primarily reflecting the time value of money and the residual risk of the outstanding European regulatory review.